An open label, single cohort, randomized, 4-period crossover Phase 1 study to determine the effect of meal timing relative to CRN00808 administration on the safety and pharmacokinetics of CRN00808 in healthy volunteers

Start Date08 Oct 2018

Sponsor / Collaborator

Crinetics Australia Pty Ltd.

[+1]

ACTRN12618001244291 / SuspendedPhase 1/2

A phase I/II study of povidone-iodine nasal spray (Nasodine”) to investigate safety and tolerability in healthy volunteers (Stage 1), and to investigate safety and efficacy in patients with the common cold (Stage 2).

Start Date30 Jul 2018

Sponsor / Collaborator

Firebrick Pharma Ltd.

[+1]

ACTRN12618001197224 / CompletedNot Applicable

A single dose, cross-over pharmacokinetic study comparing oral formulations of BNC210 in healthy male volunteers

Start Date19 Jul 2018

Sponsor / Collaborator

Bionomics Ltd.

[+1]

100 Clinical Results associated with CPR Pharma Services Pty Ltd.

0 Patents (Medical) associated with CPR Pharma Services Pty Ltd.

Literatures (Medical) associated with CPR Pharma Services Pty Ltd.

01 Jun 2019·BioanalysisQ4 · MEDICINE

12th GCC Closed Forum: Critical Reagents; Oligonucleotides; CoA; Method Transfer; HRMS; Flow Cytometry; Regulatory Findings; Stability and Immunogenicity

Q4 · MEDICINE

Article

Author: Barry, Colin ; Garofolo, Wei ; Xiao, Yi Qun ; Goodwin, Lawrence ; Xu, Allan ; DuBey, Ira ; Islam, Rafiq ; Savu, Simona Rizea ; Hays, Amanda ; St Charles, Jessica ; Thomas, Eric ; Williard, Clark ; Hristopoulos, George ; Moussallie, Marc ; Couerbe, Philippe ; Bennett, Patrick ; Kakkanaiah, Vellalore ; Lindley, Kathie ; Satterwhite, Christina ; Keyhani, Anahita ; Beaver, Chris ; Caturla, Maria Cruz ; Fang, Xinping ; Sheldon, Curtis ; Malone, Michele ; Awaiye, Kayode ; Zimmer, Jennifer ; Ritzén, Hanna ; Cape, Stephanie ; Wells, Edward ; Yu, Mathilde ; Wang, Hao ; Dinan, Andrew ; Hughes, Nicola ; Williams, Dave ; Estdale, Sian ; Spriggs, Franklin ; Nehls, Corey ; Hayes, Roger ; Brown, Michael ; MacNeill, Robert ; Khadang, Ardeshir ; Briscoe, Chad ; Vija, Jenifer ; Tabler, Edward ; Lowes, Steve ; Savoie, Natasha ; Di Marco, Chantal ; Boulay, Iohann ; Karnik, Shane ; Kulagina, Nadia ; Lindsay, John ; Warren, Mark ; Bouhajib, Mohammed ; Lin, Jenny ; Rhyne, Paul ; Bourdage, James ; Stamatopoulos, John ; Matassa, Luca ; Tayyem, Rabab ; Stouffer, Bruce ; Xu, Arron

The 12th GCC Closed Forum was held in Philadelphia, PA, USA, on 9 April 2018. Representatives from international bioanalytical Contract Research Organizations were in attendance in order to discuss scientific and regulatory issues specific to bioanalysis. The issues discussed at the meeting included: critical reagents; oligonucleotides; certificates of analysis; method transfer; high resolution mass spectrometry; flow cytometry; recent regulatory findings and case studies involving stability and nonclinical immunogenicity. Conclusions and consensus from discussions of these topics are included in this article.

01 Apr 2019·BioanalysisQ4 · MEDICINE

Recommendations for Classification of Commercial LBA Kits for Biomarkers in Drug Development From the GCC for Bioanalysis

Q4 · MEDICINE

Article

Author: Keyhani, Anahita ; Hughes, Nicola ; Williard, Clark ; Malone, Michele ; Bourdage, James ; Satterwhite, Christina ; Warren, Mark ; Lin, Jenny ; Zimmer, Jennifer ; Kulagina, Nadia ; Bouhajib, Mohammed ; Barry, Colin ; Nehls, Corey ; Stamatopoulos, John ; Wang, Hao ; Kakkanaiah, Vellalore ; Thomas, Eric ; Savu, Simona Rizea ; Wells, Edward ; Briscoe, Chad ; Brown, Michael ; Kar, Sumit ; Cape, Stephanie ; Lindley, Kathie ; DiMarco, Chantal ; Hayes, Roger ; MacNeill, Robert ; Couerbe, Philippe ; St Charles, Jessica ; Yu, Mathilde ; Awaiye, Kayode ; Vija, Jenifer ; Spriggs, Franklin ; DiMarco, Luigi ; Cruz Caturla, Maria ; Garofolo, Wei ; Lindsay, John ; Hays, Amanda ; Karnik, Shane ; Sheldon, Curtis ; Feng, Hao ; Xu, Allan ; Dinan, Andrew ; DuBey, Ira ; Bennett, Patrick ; Savoie, Natasha ; Goodwin, Lawrence ; Fang, Xinping ; Moussallie, Marc ; Tabler, Edward ; Williams, Dave ; Boulay, Iohann ; Islam, Rafiq ; Ritzén, Hanna ; Xiao, Yi Qun ; Rhyne, Paul ; Stouffer, Bruce ; Tayyem, Rabab ; Hristopoulos, George ; Beaver, Chris ; Estdale, Sian ; Khadang, Ardeshir ; Xu, Arron

Over the last decade, the use of biomarker data has become integral to drug development. Biomarkers are not only utilized for internal decision-making by sponsors; they are increasingly utilized to make critical decisions for drug safety and efficacy. As the regulatory agencies are routinely making decisions based on biomarker data, there has been significant scrutiny on the validation of biomarker methods. Contract research organizations regularly use commercially available immunoassay kits to validate biomarker methods. However, adaptation of such kits in a regulated environment presents significant challenges and was one of the key topics discussed during the 12th Global Contract Research Organization Council for Bioanalysis (GCC) meeting. This White Paper reports the GCC members’ opinion on the challenges facing the industry and the GCC recommendations on the classification of commercial kits that can be a win-win for commercial kit vendors and end users.

01 Apr 2018·BioanalysisQ4 · MEDICINE

11th GCC Closed Forum: Cumulative Stability; Matrix Stability; Immunogenicity assays; Laboratory Manuals; Biosimilars; Chiral methods; Hybrid LBA/LCMS Assays; Fit-for-Purpose Validation; China Food and Drug Administration Bioanalytical Method Validation

Q4 · MEDICINE

Article

Author: Tudoroniu, Ariana ; Garofolo, Wei ; Spriggs, Franklin ; Savoie, Natasha ; Hulse, James ; Bouhajib, Mohammed ; Fatmi, Saadya ; van der Strate, Barry ; Wilfahrt, Jim ; Warren, Mark ; Williard, Clark ; Fountain, Scott ; Bourdage, James ; Beaver, Chris ; Arnold, Mark ; Zemo, Jennifer ; Hayward-Sewell, Joanne ; Colletti, Kelly ; Karnik, Shane ; DuBey, Ira ; Brant, Ashley ; Patel, Vimal ; Dinan, Andrew ; Liu, Yansheng ; Lin, Jenny ; Sanchez, Christina ; Stouffer, Bruce ; Datin, Jim ; Yamashita, Jim ; Fang, Xinping ; Iordachescu, Adriana ; Sikkema, Daniel ; Briscoe, Chad ; Ray, Gene ; Stamatopoulos, John ; Khadang, Ardeshir ; Lindsay, John ; Xu, Allan ; Brown, Michael ; Yu, Mathilde ; Xiao, Yi Qun ; Wells, Edward ; Hayes, Roger ; Cape, Stephanie ; Boudreau, Nadine ; Papac, Damon ; Hristopoulos, George ; Warrino, Dominic ; Caturla, Maria Cruz ; Tayyem, Rabab ; Keyhani, Anahita ; Couerbe, Philippe ; Khan, Masood ; Tabler, Edward ; Zimmer, Jennifer ; Tu, Jing ; Kennedy, Michael ; Sheldon, Curtis ; Marcelletti, John ; St Charles, Jessica ; Vija, Jenifer ; Satterwhite, Christina ; Islam, Rafiq ; Joyce, Philip ; Nehls, Corey ; Ohorodnik, Susan ; Green, Rachel ; Barry, Colin ; Bower, Joseph ; Buonarati, Mike ; Hughes, Nicola

The 11th Global CRO Council Closed Forum was held in Universal City, CA, USA on 3 April 2017. Representatives from international CRO members offering bioanalytical services were in attendance in order to discuss scientific and regulatory issues specific to bioanalysis. The second CRO–Pharma Scientific Interchange Meeting was held on 7 April 2017, which included Pharma representatives’ sharing perspectives on the topics discussed earlier in the week with the CRO members. The issues discussed at the meetings included cumulative stability evaluations, matrix stability evaluations, the 2016 US FDA Immunogenicity Guidance and recent and unexpected FDA Form 483s on immunogenicity assays, the bioanalytical laboratory's role in writing PK sample collection instructions, biosimilars, CRO perspectives on the use of chiral versus achiral methods, hybrid LBA/LCMS assays, applications of fit-for-purpose validation and, at the Global CRO Council Closed Forum only, the status and trend of current regulated bioanalytical practice in China under CFDA's new BMV policy. Conclusions from discussions of these topics at both meetings are included in this report.

100 Deals associated with CPR Pharma Services Pty Ltd.

100 Translational Medicine associated with CPR Pharma Services Pty Ltd.

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 23 Dec 2024

No data posted

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis

CPR Pharma Services Pty Ltd.

Overview

Related

Corporation Tree

Pipeline

Pipeline Snapshot as of 23 Dec 2024

Deal

Translational Medicine

Profit

Grant & Funding(NIH)

Investment

Financing